Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04234659 · ClinicalTrials.gov registry record
PPCM Observational Study (Peripartum Cardiomyopathy)
A clinical trial of Cardiogenic Shock and Peripartum Cardiomyopathy, sponsored by Medical College of Wisconsin.
- Completed
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT04234659: Completed study of Cardiogenic Shock and Peripartum Cardiomyopathy, sponsored by Medical College of Wisconsin.
NCT04234659 is a study of Cardiogenic Shock and Peripartum Cardiomyopathy that has completed, run by Medical College of Wisconsin. The registered enrollment target is 150 participants, below the 625-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04234659, a study of Cardiogenic Shock and Peripartum Cardiomyopathy, has completed, sponsored by Medical College of Wisconsin.
- COMPLETED
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.
Primary Outcome
The retrospective and prospective data collected from study participants will report clinical treatments required to treat the diagnosis of peripartum cardiomyopathy complicated by cardiogenic shock.
Conditions Studied
Interventions
- DEVICE Clinical placement of a temporary IMPELLA® mechanical circulatory support device.
Study Locations (1)
Wisconsin
- Medical College of Wisconsin - Milwaukee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2021-01-11 |
| Est. Completion | 2025-08-05 |
What the finished NCT04234659 record still lists
NCT04234659 is an observational study that tracks outcomes without assigning an intervention. The registered 150 participants enrollment target is mid-sized for trials with a published cap, below the 625-participant average among 16 other Cardiogenic Shock trials with a reported enrollment target (76% lower).
The record links to 2 conditions, with Cardiogenic Shock appearing as the primary indexed condition, and to 1 intervention - of which Clinical placement of a temporary IMPELLA® mechanical circulatory support device. is the first listed.
NCT04234659 reports a single indexed study location in Wisconsin.
Frequently Asked Questions
What is clinical trial NCT04234659 about?
NCT04234659 is a clinical study titled "PPCM Observational Study (Peripartum Cardiomyopathy)". The purpose of this study is to examine the clinical treatment of patients diagnosed with peripartum cardiomyopathy complicated by cardiogenic shock.
What is the current status of trial NCT04234659?
This trial is currently completed. The enrollment target is 150 participants. The study started on 2021-01-11. Estimated completion is 2025-08-05.
What conditions does trial NCT04234659 study?
This clinical trial studies the following conditions: Cardiogenic Shock, Peripartum Cardiomyopathy.
What interventions are being tested in trial NCT04234659?
The interventions under investigation include: Clinical placement of a temporary IMPELLA® mechanical circulatory support device. (DEVICE).
Who is sponsoring clinical trial NCT04234659?
This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04234659 being conducted?
This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cardiogenic Shock
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04234659's enrollment target sits among peer trials
150 7th of 16 higher than 10 of 16 other Cardiogenic Shock trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cardiogenic Shock trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Cardiac Power Output in Cardiogenic Shock Patients
RECRUITING · Early Phase 1
-
Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure
RECRUITING
-
Inova Cardiogenic Shock Registry (INOVA SHOCK)
RECRUITING
-
Pre-Emptive LAVA-ECMO for Complex High-Risk TAVR
RECRUITING
-
Left Ventricular Physiological Effects of Veno-Arterial Extracorporeal Membrane Oxygenation Support During Cardiogenic Shock
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00412594 · 150 participants · Phase 2
Cladribine and Rituximab in Treating Patients With Hairy Cell Leukemia
- NCT01484730 · 150 participants
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
- NCT01985919 · 150 participants
Protocol for Facilitating the Acquisition of Research Bone Marrow and Blood Samples
- NCT02016248 · 150 participants · NA
SBRT Boost for Unfavorable Prostate Cancer'
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI